Crossmark

Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel

Crossref DOI link: https://doi.org/10.1038/s41523-026-00910-7

Published Online: 2026-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hsieh, Cheng-Hsien

Hsu, Ming-Yi

Lin, Chiou-Feng

Liu, Chien-Chun

Kuo, Yi-Hua

Huang, Yu-Ting

Chen, Wei-Yu

Liu, Shih-Jung

Lee, Wei-Jiunn
Funding

Funding for this research was provided by:

Chang Gung Memorial Hospital, Linkou (CMRPG2N0011)

Natural Science Foundation of Fujian Province (2025J011475)

the Educational Research Project for Young and Middle-aged Teachers in Fujian Province (JZ240078)

National Natural Science Foundation of China (82502675)

Wan Fang Hospital (112-wf-eva-06)
License Information

Text and Data Mining valid from 2026-02-13

Version of Record valid from 2026-03-24
More Information

Article History

Received: 14 September 2025

Accepted: 30 January 2026

First Online: 13 February 2026

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below